Indian Pediatric Oncology Group (InPOG)
Indian Pediatric Oncology Group (InPOG)
Outcomes in paediatric oncology: Are we closing the gap between LMICs and high-income countries?
CAR-T cell therapy for ALL: Current challenges and future approaches
CART-T cell therapy in young patients with relapsed/refractory ALL
The role of blinatumomab followed by HSCT in paediatric patients with ALL
Long-term toxicities in paediatric ALL
Frontline therapy of ALL
BiTE therapy followed by HSCT vs CAR-T cells in young patients with R/R ALL
Identifying cancer susceptibility genes in paediatric ALL
Latest concepts in frontline therapy for paediatric ALL
Dasatinib vs imatinib in the treatment of paediatric ALL
FLT3-inhibition in infants with acute lymphoblastic leukaemia